PharmaSGP Holding SE (PSG) - Total Liabilities

Latest as of March 2025: €81.51 Million EUR ≈ $95.29 Million USD

Based on the latest financial reports, PharmaSGP Holding SE (PSG) has total liabilities worth €81.51 Million EUR (≈ $95.29 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PSG long-term investments to assets to see how much of total assets are deployed in long-term investments.

PharmaSGP Holding SE - Total Liabilities Trend (2014–2024)

This chart illustrates how PharmaSGP Holding SE's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see PharmaSGP Holding SE balance sheet assets.

PharmaSGP Holding SE Competitors by Total Liabilities

The table below lists competitors of PharmaSGP Holding SE ranked by their total liabilities.

Company	Country	Total Liabilities
Baader Bank Aktiengesellschaft F:BWB	Germany	€4.09 Billion
Nanjing Chervon Auto Precision Technology Co Ltd SHG:603982	China	CN¥4.33 Billion
Suzhou Fushilai Pharmaceutical Co. Ltd. SHE:301258	China	CN¥211.52 Million
Zilltek Technology Corp TWO:6679	Taiwan	NT$735.95 Million
Top Bright Holding Co Ltd TW:8499	Taiwan	NT$4.07 Billion
Bell Financial Group Ltd AU:BFG	Australia	AU$866.82 Million
Everyday Network SHE:300295	China	CN¥89.40 Million
Polisan Holding AS IS:POLHO	Turkey	TL4.20 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down PharmaSGP Holding SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See PharmaSGP Holding SE (PSG) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.68	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.69	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PharmaSGP Holding SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PharmaSGP Holding SE (2014–2024)

The table below shows the annual total liabilities of PharmaSGP Holding SE from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	€82.31 Million ≈ $96.23 Million	-10.09%
2023-12-31	€91.55 Million ≈ $107.03 Million	-6.60%
2022-12-31	€98.01 Million ≈ $114.59 Million	+5.32%
2021-12-31	€93.06 Million ≈ $108.80 Million	+592.58%
2020-12-31	€13.44 Million ≈ $15.71 Million	+64.65%
2019-12-31	€8.16 Million ≈ $9.54 Million	-63.05%
2017-12-31	€22.09 Million ≈ $25.82 Million	-1.69%
2016-12-31	€22.47 Million ≈ $26.27 Million	-4.22%
2015-12-31	€23.46 Million ≈ $27.42 Million	+16.53%
2014-12-31	€20.13 Million ≈ $23.53 Million	--

About PharmaSGP Holding SE

F:PSG Germany

Market Cap

$387.63 Million

€331.56 Million EUR

Market Cap Rank

#14454 Global

#1448 in Germany

Share Price

€28.80

Change (1 day)

+0.00%

52-Week Range

€28.80 - €28.80

All Time High

€32.32